Prostate Cancer Clinical Trials in Salt Lake City

Showing 121-140 of 303 trials

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

NCT06520345

The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with Androgen Receptor Pathway Inhibitor Treatment

Metastatic Castration-resistant Prostate Cancer

Telix Pharmaceuticals (Innovations) Pty Limited430 participantsStarted Jul 2024

Orange, California, United States • Miami, Florida, United States • Glen Burnie, Maryland, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

NCT03072238

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of ipatasertib plus abiraterone and prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate cancer (mCRPC).

Metastatic Prostate Cancer

Hoffmann-La Roche1,101 participantsStarted Jun 2017

Chandler, Arizona, United States • Scottsdale, Arizona, United States • Duarte, California, United States +173 more locations

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

LTFU for All Cell and Gene Therapy Studies

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

MGD019 DART® Protein in Unresectable/Metastatic Cancer

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

Other Conditions in Salt Lake City